Major Program
Supportive Care and Symptom Management
Research Group
Community Oncology and Prevention Trials
Sponsor
Masonic Cancer Center, University of Minnesota
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT02074631
This is a Phase 2, open-label, randomized, controlled clinical study of pediatric subjects treated with pamidronate with calcium and vitamin D versus calcium and vitamin D alone following hematopoietic cell transplantation (HCT). The purpose of this study is to test the hypothesis that subjects receiving pamidronate with calcium and vitamin D will have higher lumbar spine bone mineral content (LBMC) measured by dual-energy X-ray tomography (DXA) at 1 year post-HCT than subjects receiving calcium and vitamin D alone (Control Group).
Intervention
Pamidronate, Calcium and vitamin D
Condition
Osteopenia, Osteoporosis
Investigators
Kyriakie Sarafoglou, MD